Frogman, yes we have made progress to the point where I think we are pretty well agreed on the facts and from this point on it comes down to the difference of our opinions with regard to all the ifs, whens, and probablities.
I do have a follow up question to my last question. You have avoided calling the Super EPO a drug in favor of "experimental compound." This is a bit ambiguous. Are you saying that it is not a drug because it has not gone through clinical trials, or are you saying it is not a drug because the compound needs further refinement (changes in the chemistry of the molecule) before it is in its final "drug" form and ready for clinical trials.
Virgil